1Schachter H.The subcellular sites of glycosylation[J].Biochem Soc Symp,1974;40:57-71.
2Javaud C,Dupuy F,Maftah A et al.The fucosyltransferase gene family:an amazing summary of the underlying mechanisms of gene evolution[J].Genetica,2003;118(2-3):157-170.
3Taniguchi N,Miyoshi E,Ko J H et al.Implication of N-acetylglucosaminyltransferases III and V in cancer:generegulation and signaling mechanism[J].Biochim Biophys Acta,1999;1455(2-3):287-300.
4Harduin-Lepers A,Vallejo-Ruiz V,Krzewinski-Recchi M A et al.The human sialyltransferase family[J].Biochimie,2001;83(8):727-737.
5Arnold J N,Wormald M R,Sim R B et al.The impact of glycosylation on the biological function and structure of human immunoglobulin's[J].Ann Rev Immunol,2007;25:21-50.
6Malhotra R,Wormald M R,Rudd P M et al.Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein[J].Nat Med,1995;1(3):237-243.
7Mimura Y,Church S,Ghirlando R et al.The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc:properties of a series of truncated glycoforms[J].Mol Immunol,2000;37(12-13):697-706.
8Gala F A,Morrison S L.The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1[J].J Biol Chem,2002;277(32):29005-20911.
9Mimura Y,Sondermann P,Ghirlando R et al.Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding[J].J Biol Chem,2001;276:45539-45547.
10Gong M,Garige M,Hirsch K et al.Liver Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase is down-regulated inhuman alcoholics:possible cause for the appearance of asialoconjugates[J].Metabolism,2007;56(9):1241-1247.
5Schlieben D J, Korbet SM, Kimura RE, et al. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs[J]. Am J Kidney Dis, 2005, 45: 758-761.
6Arimura Y, Minoshima S, Kamiya Y, et al. Serum myeloper- oxidase and serum cytokines in anti-myeloperoxidase antibody- associated glomerulonephritis [J]. Clin Nephrol, 1993, 40: 256- 264.
7Terrier B, Saadoun D, Sene D, et al. Antimyeloperoxidase anti- bodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides[J]. Ann Rheum Dis, 2009, 68: 1564-1571.
8Xiao H, Heeringa P, ttu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulone- phritis and vasculitis in mice[J]. J Clin Invest, 2002, 110: 955- 963.
9Little MA, Smyth L, Salama AD, et al. Experimental autoim- mune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-assoeiated systemic vasculitis [J]. Am J Pathol, 2009, 174: 1212-1220.
10Nagao T, Matsumura M, Mabuchi A, et al. Up-regulation of adhesion molecule expression in glomerular endothelial ceils by anti-myeloperoxidase antibody[J]. Nephrol Dial Transplant, 2007, 22: 77-87.
